Zusammenfassung
Die Therapie-Resistenz auf die Behandlung mit Antidepressiva ist ein Problem, mit welchem praktizierende Ärzte in zunehmendem Maße konfrontiert sind. Immerhin sprechen ca. 30%-35% der depressiven Patienten ungenügend oder gar nicht auf eine pharmakologische Behandlung an.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Åsberg M, Bertilsson L (1979) Serotonin in depressive illness. In: Saletu B, Berner P, Hollister LE (Hrsg) Studies of CSF 5-HIAA in Neuropsychopharmacology. Pergamon Press, New York, pp 105–115
Banki CM, Molnar G, Vojnik M (1981) Cerebrospinal fluid amine metabolites, tryptophane and clinical parameters in depression. J Affect Dis 3:91–99
Carlsson A et al. (1969) Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine. Eur J Pharmacol 5:357–366
Delini-Stula A (1983) Pharmakologie der Antidepressiva. In: Larger G, Heimann H (Hrsg) Psychopharmaka, Grundlagen und Therapie. Springer Verlag, Berlin Heidelberg New York Tokyo, pp 81–95
Delini-Stula A (1987) Biochemische Klassifizierung der Antidepressiva und deren klinische Validierung. In: Simhandl Ch et al. (Hrsg) Moderne Psychiatrie, Klassifikationsprobleme in der Psychiatrie. MVP Verlag, Purkersdorf, pp 131–148
Delini-Stula A, Schiwy W (1989) Verhütung von Panikattacken mit Imipramin und Clomipramin: Pharmakologische Begründung und Zusammenfassung der klinischen Befunde. In: Kielholz P, Adams P (Hrsg) Die Vielfalt von Angstzuständen. Deutscher Ärzte-Verlag, Köln, pp 177–187
Eriksson EL (1987) Brain neurotransmitters in panic disorders. Acta Psych Scand [Suppl 335] 76:31–39
Flament MF et al. (1987) Biochemical changes during clomipramine treatment in childhood obsessive- compulsive disorder. Acta Gen Psychiatr 44 [3]:219–225
Healy D, Carney PA, Leonard BE (1982) Monoamine-related markers of depression: Changes following treatment. J Psych Res 17 [3]:251–260
Healy D, Carney PA, Leonard BE (1984) Biochemical correlates of antidepressant response. Results of a trazodone versus amitriptyline trial. Psychopathology 17 [Suppl 2]:82–87
Lapin IP, Oxenkrug GF (1969) Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1:132–136
Lecrubier Y, Puech AJ, Boyer P (1990) The contribution of neuropharmacology to the understanding of ill-defined psychological disorders. In: Sartorius N et al. (eds) Psychological disorders in general medical settings. Hogrefe & Huber Publ, Toronto Lewiston New York Bern Stuttgart, pp 98–110
Maas JW et al. (1982) Pre-treatment neurotransmitter metabolites in response to imipramine and amitriptyline treatment. Psych Med 12:37–43
Maas JW et al. (1984) Pre-treatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. Am J Psychiatr 141:1159–1171
Maitre L et al. (1980) Amine uptake inhibitors: Criteria of selectivity. In: Svensson TH, Carlsson A (eds) Biogenic amines and affective disorders. Acta Psych Scand 61 [Suppl 280]: p 97–110
Maitre L et al. (1982) 5-HT uptake inhibitors: Psychopharmacological and biochemical criteria of selectivity. In: Ho BT, Schoolar JC, Usdin E (eds) Advances in biochemical psychopharmacology. Serotonin in biological psychiatry. Raven Press, New York, pp 229–246
Mouret J, Lemoine P, Minuit M-P (1987) Marquers polygraphiques, cliniques et thérapeutiques des dépressions dopamine-dépendantes (DDD). CR Acad Sci, Vol 305, series III:301–306
Randrup A et al. (1975) Mania, depression and brain dopamine. In: Essmann WB, Valzelli L (eds) Current developments in psychopharmacology, vol 2. Spectrum Publ, New York, pp 205–248
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatr 122:509–522
Timmerman L et al. (1987) A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients. Int Clin Psychopharm 2:239–253
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Delini-Stula, A. (1990). Pharmakologische Grundlage der ‚Therapieresistenz‘ bei der Behandlung mit Antidepressiva. In: Möller, HJ. (eds) Therapieresistenz unter Antidepressiva-Behandlung. Tropon-Symposium, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84236-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-84236-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52765-7
Online ISBN: 978-3-642-84236-8
eBook Packages: Springer Book Archive